Compound Libraries

A unique collection of 1016 tyrosine kinase inhibitors for high throughput screening and high content screening for drug discovery in tyrosine kinase related diseases;

A unique collection of 1147 compounds targeting ion channels for research in ion channels-related diseases and ion channel drug discovery;

A unique collection of 784 compounds targeting endocrine system for high throughput screening (HTS) and high content screening (HCS) for new drugs;

A collection of 499 selected human endogenous metabolites for high throughput and high content screening.

A unique collection of 492 compounds targeting lipid metabolism, can be used for high-throughput screening (HTS) and high-content screening (HCS).

702 glycometabolism-related comounds, can be used for HTS and HCT;

A unique collection of 218 mouse metabolites, which can be used for HTS and HCS;

A unique collection of 540 gut microbial metabolites which can be used for HTS and HCS;

A unique collection of 565 glutamine metabolism related compounds can be used for high throughput screening (HTS) and high content screening (HCS), and also is an effective tool for research in glutamine metabolism and cancer;